Previous Close | N/A |
Open | N/A |
Bid | N/A |
Ask | N/A |
Strike | N/A |
Expire Date | N/A |
Day's Range | N/A - N/A |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
(Bloomberg) -- Dental implants manufacturer ZimVie Inc. is weighing options including a sale after getting fresh takeover approaches, according to people with knowledge of the matter. Most Read from BloombergYouTuber Dr Disrespect Was Allegedly Kicked Off Twitch for Messaging MinorNvidia Rout Takes Breather as Traders Scour Charts for SupportTrump Could Actually Lose Florida. Here’s Why.Rivian to Form EV Venture With $5 Billion From VolkswagenPaul Singer Is Pitching Wall Street's Own Brand of MA
PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences. ZimVie will be presenting at the upcoming Stifel 2024 Jaws & Paws Conference. ZimVie’s management is scheduled to present on Thursday, May 30, 2024, at 11:30 a.m. Eastern Time. ZimVie’s management will also be presenting at the 45th Annual Goldman Sachs Global Healthc
ZimVie Inc. (NASDAQ:ZIMV) Q1 2024 Earnings Call Transcript May 11, 2024 ZimVie Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to ZimVie’s First Quarter 2024 Earnings Conference Call. Currently, all participants are in a listen-only […]